MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Vaccine Development & Manufacturing
Themis Bioscience
Attachments
Themis BIO
Parents
*Architects: Vaccine Development & Manufacturing
Adjuvant Capital
Companies: Acquired_(M&A)
Finance & Acquisitions: Merck & Co.
Industry: Austria
Children
2020: Merck to acquire Austrian vaccine maker Themis Bioscience
Founded 2009
The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases.
Themis Bioscience is developing vaccines to prevent infectious diseases.
Vienna, Austria
Jumps
Center for Vaccine Research, University of Pittsburgh
Pasteur Institute